Metraipolis › archive › dc_fd4eb26cb0f8
Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma: a systematic review… — Europe PMC PMID:41458593
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41458593
- DOI
- 10.3389/fonc.2025.1707622
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:45:59.719Z
- SHA-256 of the archived text
94dbab49e32d6ff12b0da69dab6f12c490fc397fc7d75f150f550c276bb38884- Stable URL of this page
https://metraipolis.com/documento/dc_fd4eb26cb0f8
How to cite
Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma: a systematic review… — Europe PMC PMID:41458593 — Europe PMC (en), https://europepmc.org/article/MED/41458593 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd4eb26cb0f8 (Metraipolis archive dc_fd4eb26cb0f8, sha256 94dbab49e32d6ff12b0da69dab6f12c490fc397fc7d75f150f550c276bb38884)
BibTeX
@misc{dcfd4eb26cb0f8,
title = {Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma: a systematic review… — Europe PMC PMID:41458593},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41458593},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd4eb26cb0f8; sha256 94dbab49e32d6ff12b0da69dab6f12c490fc397fc7d75f150f550c276bb38884},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41458593. Agents can read the archived copy with the MCP tool read_document.